Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Documenti analoghi

• Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
  di: Cometta, A, et al.
  Pubblicazione: (1995)
• Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.
  di: Meunier, F, et al.
  Pubblicazione: (1991)
• Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
  di: Klastersky, J, et al.
  Pubblicazione: (1986)
• Prospective Randomized Comparison of Three Antibiotic Regimens for Empirical Therapy of Suspected Bacteremic Infection in Febrile Granulocytopenic Patients
  di: Klastersky, Jean, et al.
  Pubblicazione: (1986)
• Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
  di: Musto, Pellegrino, et al.
  Pubblicazione: (2015)